Otras formas específicas de cefaleas primarias: cefaleas trigémino autonómicas y neuralgias

  1. Abedrabbo, F. 1
  2. Villino, R. 1
  3. Sánchea del Río, M. 2
  4. Irimia, P. 1
  1. 1 Departamentos de Neurología, Clínica Universidad de Navarra, Pamplona, España
  2. 2 Departamentos de Neurología, Clínica Universidad de Navarra, Madrid, España
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Any de publicació: 2023

Títol de l'exemplar: Enfermedades del sistema nervioso (II): Cefaleas

Sèrie: 13

Número: 71

Pàgines: 4176-4185

Tipus: Article

DIALNET GOOGLE SCHOLAR

Altres publicacions en: Medicine: Programa de Formación Médica Continuada Acreditado

Resum

Trigeminal autonomic cephalalgias (TAC) and craniofacial neuralgias are other forms of primary headaches that are uncommon but very debilitating. Four clinical syndromes are encompassed within the term TAC: cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache, and hemicrania continua. A common feature of TAC is the presence of strictly unilateral pain in the trigeminal area with accompanying autonomic symptoms. They are differentiated according to the different frequencies and durations of the episodes and the pharmacological response. Each of these syndromes has well-defined clinical criteria and specific treatments. On the other hand, trigeminal neuralgia is the most common type of neuralgia and is clinically defined by very short, high-intensity episodes of pain of a stabbing nature distributed in one or more branches of the trigeminal nerve. The drug of choice in trigeminal neuralgia continues to be carbamazepine and, in patients who do not respond to medical treatment, surgery with ablative or microvascular decompression techniques should be evaluated. Occipital neuralgia is characterized by episodes of pain that are usually stabbing located in the distribution of occipital nerves. The most common initial treatment is occipital nerve block, which has diagnostic value and provides rapid symptoms relief.

Referències bibliogràfiques

  • Pedraza MI, Mulero P, Ruíz M, de la Cruz C, Herrero S, Guerrero AL. Characteristics of the first 2,000 patients registered in a specialist headache clinic. Neurología. 2015;30:208-13.
  • Trejo Gabriel-Galán JM, Aicua Rapún I, Cubo Delgado E, Velasco Bernal. Suicide in primary headaches in 48 countries: A physician-survey based study. Cephalalgia. 2018;38:798-803.
  • Buture A, Ahmed F, Dikomitis L, Boland JW. Systematic literature review on the delays in the diagnosis and misdiagnosis of cluster headache. Neurol Sci. 2019;40:25-39
  • Latorre G, González García N, García Ull J, González Oria C. Diagnóstico y tratamiento de la neuralgia del trigémino: documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología. Neurología. En prensa 2022.
  • Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum (Minneap Minn). 2012;18:883.
  • Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight Project. J Headache Pain. 2010;11:289-99.
  • Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol. 2009;8:755.
  • Matharu M, May A. Functional and structural neuroimaging in trigeminal autonomic cephalalgias. Curr Pain Headache Rep. 2008;12:132-7.
  • Leone M, Franzini A, Proietti Cecchini A, Mea E, Broggi G, Bussone G. Deep brain stimulation in trigeminal autonomic cephalalgias. Neurotherapeutics. 2010;7:220-8.
  • May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet. 2005;366:843.
  • Malu OO, Bailey J, Hawks MK. Cluster Headache: Rapid evidence review. Am Fam Physician. 2022;105:24-32.
  • Pareja Grande JA, Caminero AB, García Azorín D, Ordás Bandera C Bandera, Santos Lasosa S. Cefaleas trigémino-autonómicas. En: Santos Lasaosa, Pozo Rosich P, editores. Manual de práctica clínica en cefaleas. Recomendaciones Diagnóstico-Terapéuticas de la Sociedad Española de Neurología. Madrid: Luzán 5; 2020. p. 166-90
  • Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autono- mic feature, including new cases. Brain. 1997;12 (Pt1):193-209.
  • Cohen AS. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia. 2007; 27:824.
  • Prakash S, Patel P. Hemicrania continua: clinical review, diagnosis and management. J Pain Res. 2017;10:1493.
  • Long RJ, Zhu YS, Wang AP. Cluster headache due to structural lesions: A systematic review of published cases. World J Clin Cases. 2021;9:3294.
  • Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018;17:75 .
  • Miller S, Correia F, Lagrata S, Matharu MS. OnabotulinumtoxinA for hemicrania continua: open label experience in 9 patients. J Headache Pain. 2015;16:19.
  • Lambru G, Lagrata S, Levy A, Cheema S, Davagnanam I, Rantell K. Trigeminal microvascular decompression for short-lasting unilateral neuralgiform headache attacks. Brain. 2022;145(8):2882-93.
  • Pozo Rosich, P, Alpuente A, Fabregat N, Jiménez MD, Viguera J. Neuropatías craneales dolorosas y otros dolores faciales. En: Santos Lasaosa, Pozo Rosich P, editores. Manual de práctica clínica en cefaleas. Recomendaciones Diagnóstico-Terapéuticas de la Sociedad Española de Neurología. Madrid: Luzán 5; 2020.p. 315-41.
  • Cruccu G, Di Stefano G, Truini A. Trigeminal neuralgia. N Engl J Med. 2020;383:754-76.
  • Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26:831-49.
  • Pan W, Peng J, Elmofty D. Occipital neuralgia. Curr Pain Headache Rep. 2021:25:61
Fuente de los datos: Dialnet